This oncogenic–tumor-suppressive dichotomy underscores the importance of context in ADAR biology and highlights the potential of ADAR-targeted interventions whether through inhibition of ADAR1 or restoration of ADAR2—as promising strategies in precision oncology for GC. Here, ADARB1 is linked to neoplasm.